Report on the Fair Pricing Forum 2017. Amsterdam, The Netherlands, 11 May 2017
(2017; 15 pages)


The main aim of the Forum, held on the 11th May 2017 in Amsterdam, was to enable stakeholders to discuss options for a fairer pricing system that is sustainable for both health systems and the pharmaceutical industries.

The Forum sought to address three questions:

  • What can governments do to ensure fairer medicines prices and greater access?
  • What can industry do?
  • How can WHO support the process?

Key issues addressed included: developing alternative approaches for research and development (R&D) and business models for innovation; facilitating collaboration among payers by expanding current networks to include other relevant stakeholders and countries; increasing exchange of information, for example to assess the value of new products; promoting transparency of prices paid, R&D costs, production costs, and profit margins.

The Forum was hosted by the Dutch Ministry of Health, Welfare and Sport together with WHO, and attended by representatives from non-governmental and patient organizations and Member States (Annex A) and the pharmaceutical industry. The forum was divided into two parts – an interactive plenary session in the morning, based on a series of four short films addressing different aspects of the pricing/access issue, followed by breakout sessions in the afternoon covering related themes (Annex B).

The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018